Pulmatrix, Inc. Common Stock
PULM Real Time Price USDRecent trades of PULM by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by PULM's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
-
$16,000 Feb 03, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$16,000 Oct 06, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$16,000 Jul 15, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$17,000 Apr 09, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$16,000 Jan 20, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$16,000 Nov 09, 2009 Issue: Medical/Disease Research/Clinical Labs
-
$16,000 Jul 13, 2009 Issue: Medical/Disease Research/Clinical Labs
-
$16,000 Apr 21, 2009 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2008 Issue: Budget/Appropriations
-
$20,000 Jul 21, 2008 Issue: Budget/Appropriations
-
$20,000 Apr 21, 2008 Issue: Budget/Appropriations
Estimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
-
Patent Title: Monovalent metal cation dry powders for inhalation May. 09, 2017
-
Patent Title: Cationic dry powders Sep. 06, 2016
-
Patent Title: Dry powder formulations and methods for treating pulmonary diseases Jan. 12, 2016
-
Patent Title: Dry powder formulations and methods for treating pulmonary diseases Jun. 23, 2015
-
Patent Title: Respirably dry powder comprising calcium lactate, sodium chloride and leucine Mar. 31, 2015
-
Patent Title: Respirably dry powder comprising calcium lactate, sodium chloride and leucine Jun. 24, 2014
-
Patent Title: Method and device for decreasing contamination Jan. 14, 2014
-
Patent Title: Formulations decreasing particle exhalation Nov. 26, 2013
-
Patent Title: Formulations decreasing particle exhalation May. 29, 2012
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of PULM in WallStreetBets Daily Discussion
Recent insights relating to PULM
Recent picks made for PULM stock on CNBC
ETFs with the largest estimated holdings in PULM
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PULM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.